Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.

MLA

Porta, Camillo, et al. “Management of Adverse Events Associated with the Use of Everolimus in Patients with Advanced Renal Cell Carcinoma.” European Journal of Cancer (Oxford, England : 1990), vol. 47, no. 9, June 2011, pp. 1287–98. EBSCOhost, https://doi.org/10.1016/j.ejca.2011.02.014.

APA

Porta, C., Osanto, S., Ravaud, A., Climent, M.-A., Vaishampayan, U., White, D. A., Creel, P., Dickow, B., Fischer, P., Gornell, S. S., Meloni, F., & Motzer, R. J. (2011). Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma. European Journal of Cancer (Oxford, England : 1990), 47(9), 1287–1298. https://doi.org/10.1016/j.ejca.2011.02.014

Chicago

Porta, Camillo, Susanne Osanto, Alain Ravaud, Miguel-Angel Climent, Ulka Vaishampayan, Dorothy A White, Patricia Creel, et al. 2011. “Management of Adverse Events Associated with the Use of Everolimus in Patients with Advanced Renal Cell Carcinoma.” European Journal of Cancer (Oxford, England : 1990) 47 (9): 1287–98. doi:10.1016/j.ejca.2011.02.014.